n.a secondary consequence
SQ109 to be evaluated for efficacy on multi-drug resistant patients
Russia: Infectex initiates enrollment in SQ109 Phase IIb-III trial for MDR-TB
Compositions and methods for treatment of infectious disease
Activity of SQ641, a Capuramycin Analog, in Murine Models of Tuberculosis (TB)
Evaluation of SQ109 Plus PPI in Urea Breath Test-Positive Volunteers
Compositions and methods for the treatment of infectious diseases
Two new tuberculosis drugs show significant synergy in vitro
Anti-tubercular drugs: compositions and methods
Sequella Commences Phase 1B Study For New Tuberculosis Drug SQ109
Sequella Receives International Support For Phase 2 Clinical Trials Of SQ109, Its Lead Antitubercular Drug Candidate
